1.Bartlett, JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334–339.
2.McDonald, LC, Owings, M, Jernigan, D. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerglnfect Dis 2006;12:409–415.
3.Noren, T, Tang-Feldman, YJ, Cohen, SH, Silva, I Jr, Oleen, P. Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis 2002;42:149–151.
4.Ricciardi, R, Rothenberger, DA, Madoff, RD, Baxter, NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142:624–631.
5.Redelings, M, Sorvillo, F, Mascola, L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007;13:1417–1419.
7.Kutty, PK, Benoit, SR, Woods, CW, et al.Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol 2008;29:197–202.
8.Loo, VG, Poirier, L, Miller, MA, et al.A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442–2449.
9.Pepin, J, Valiquette, L, Cossette, B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005;173:1037–1042.
10.Dubberke, ER, Butler, AM, Reske, KA, et al.Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008;14:1031–1038.
11.Olson, MM, Shanholtzer, CI, Lee, IT Jr, Gerding, DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994;15:371–381.
12.Miller, MA, Hyland, M, Ofner-Agostini, M, Gourdeau, M, Ishak, M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002;23:137–140.
13.Miller, MA, Gravel, D, Mulvey, M, et al.Surveillance for nosocomial Clostridium difficile-associated diarrhea (N-CDI) within acute-care hospitals in Canada: results of the 2005 nosocomial infections surveillance program (CNISP) study shows escalating mortality. In: Program and Abstracts of the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA). Arlington, VA: SHEA, 2006:108. Abstract 151.
14.Riggs, MM, Sethi, AK, Zabarsky, TF, Eckstein, EC, Jump, RL, Donskey, CI. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007;45:992–998.
15.Fung, CH, Lim, YW, Mattke, S, Damberg, C, Shekelle, PG. Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann Intern Med 2008;148:111–123.
16.Tan, ET, Robertson, CA, Brynildsen, S, Bresnitz, E, Tan, C, McDonald, C. Clostridium difficile-associated disease in New Jersey hospitals, 2000-2004. Emerg Infect Dis 2007;13:498–500.
17.Dubberke, E, Yokoe, DS, Mayer, J, et al.Multicenter study of Clostridium difficile-associated disease rates from 2000-2006. In: Program and Abstracts of the 16th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (SHEA). Arlington, VA: SHEA, 2008:62. Abstract 52.
18.Chang, HT, Krezolek, D, Johnson, S, Parada, IP, Evans, CT, Gerding, DN. Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol 2007;28:926–931.
19.McDonald, LC, Coignard, B, Dubberke, E, et al.Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140–145.
20.Kyne, L, Hamel, MB, Polavaram, R, Kelly, CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002;34:346–353.
21.Dubberke, ER, Reske, KA, Olsen, MA, McDonald, LC, Fraser, VJ. Short-and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008;46:497–504.
22.Johnson, S, Samore, MH, Farrow, KA, et al.Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999;341:1645–1651.
23.Muto, CA, Blank, MK, Marsh, JW, et al.Control of an outbreak of infection with the Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis 2007;45:1266–1273.
24.Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45(suppl 2):S112–S121.
25.Pronovost, P, Needham, D, Berenholtz, S, et al.An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl I Med 2006;355:2725–2732.
26.Reduction in central line-associated bloodstream infections among patients in intensive care units—Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep 2005;54:1013–1016.